Bristol-Myers (BMY) Q3 Earnings & Sales Beat, Opdivo Sales Grow

Bristol-Myers Squibb Company reported better-than-expected results for the third quarter of 2023 and updated its annual outlook for earnings. The company reported adjusted earnings per share of $2, which beat the Zacks Consensus Estimate of $1.76. In the year-ago quarter, BMY posted adjusted earnings per share of $1.99.